SCHEMBL906337

SCHEMBL906337

[CH2]Cc1cncn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178520 0.83 — —
Hydrochloric Acid SCHEMBL27926323 0.81 — —
SCHEMBL4300091 0.79 — —
SCHEMBL12722883 0.79 — —
SCHEMBL25404428 0.77 — —
SCHEMBL451875 0.76 — —
SCHEMBL240920 0.76 — —
SCHEMBL20245292 0.76 — —
SCHEMBL5262990 0.76 — —
SCHEMBL8864900 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294699-B1 MODULATORS OF TNF- ALPHA SIGNALLING GENZYME CORP (US) 2016-04-13 — — EP claimed
US-8518999-B2 Modulators of TNF-αsignaling GENZYME CORPORATION (US) 2013-08-27 — — US claimed
CN-100494182-C Regulatory factor of tumor necrosis alpha factor GENZYME CORP (US) 2009-06-03 — — CN claimed
EP-1420747-A2 BENZOQUINONE ANSAMYCINS Kosan Biosciences, Inc. (US) 2004-05-26 — — EP claimed
CN-1441787-A Modulators of TNF-alpha signaling GENZYME CORP (US) 2003-09-10 — — CN claimed
US-20030114450-A1 Anticancer agents; antiproliferative agent KOSAN BIOSCIENCES, INC. 2003-06-19 — — US claimed
WO-2003013430-A2 BENZOQUINONE ANSAMYCINS KOSAN BIOSCIENCES, INC. (US) 2003-02-20 — — WO claimed
JP-H09503518-A — — 1997-04-08 — — JP claimed
EP-0722447-A1 3-PYRROLIDINYLTHIO-CARBAPENEM DERIVATIVES AND THEIR ANTIMICROBAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-07-24 — — EP claimed
WO-1995010520-A1 3-PYRROLIDINYLTHIO-CARBAPENEM DERIVATIVES AND THEIR ANTIMICROBAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-04-20 — — WO claimed
US-20150038541-A1 COMPOSITION AND METHODS FOR CELL MODULATION APOSIGNAL BIOSCIENCE LLC (US) 2015-02-05 — — US disclosed
EP-2827861-A1 COMPOSITION AND METHODS FOR CELL MODULATION Aposignal Bioscience LLC (US) 2015-01-28 — — EP disclosed
WO-2013142376-A1 COMPOSITION AND METHODS FOR CELL MODULATION APOSIGNAL BIOSCIENCE LLC (US) 2013-09-26 — — WO disclosed
EP-2243033-B1 THERMAL DENATURATION SCREENING ASSAY TO IDENTIFY CANDIDATE COMPOUNDS FOR PREVENTION AND TREATMENT OF PARKINSON'S DISEASE ELAN PHARMA INT LTD (IE) 2012-06-06 — — EP disclosed
EP-2276482-A2 HSP90 INHIBITORS OR MODULATORS FOR TREATMENT OR PREVENTION OF SUBSTANCE-RELATED DISORDERS The Regents of the University of California (US) 2011-01-26 — — EP disclosed
EP-0004466-B1 DEMETHYL MAYTANSINOIDS AND METHODS FOR PRODUCING THEM Takeda Chemical Industries, Ltd. (JP) 1982-01-27 — — EP disclosed
US-4307016-A FUNGICIDES, PROTOZOACIDES OR ANTITUMOR AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-22 — — US disclosed
US-4294757-A BLEACHING CELLULOSE FIBERS AND ADDITION OF ALKALI METAL POLYPHOSPHATES AND ALKALI METAL DIETHYLENETRIAMINE PENTA(METHYLENE PHOSPHONAT) TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 1981-10-13 — — US disclosed
EP-0014402-A1 Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them Takeda Chemical Industries, Ltd. (JP) 1980-08-20 — — EP disclosed
EP-0004466-A1 Demethyl maytansinoids and methods for producing them Takeda Chemical Industries, Ltd. (JP) 1979-10-03 — — EP disclosed
Send feedback